|Symbol||Name||Price (Intraday)||Change||% Change||Volume||Avg Vol (3 month)||Market Cap||PE Ratio (TTM)||52 Week Range|
|EDIT||Editas Medicine, Inc.||34.67||-6.31||-15.40%||6.752M||2.421M||2.335B||N/A|
|PCT||PureCycle Technologies, Inc.||25.98||-2.17||-7.71%||697,455||596,595||3.074B||N/A|
|MARA||Marathon Digital Holdings, Inc.||38.93||-3.21||-7.62%||23.728M||26.415M||3.846B||N/A|
|RIOT||Riot Blockchain, Inc.||44.64||-3.47||-7.21%||24.637M||28.665M||3.755B||N/A|
|STT||State Street Corporation||80.43||-6.08||-7.03%||5.627M||3.006M||28.031B||13.25|
|OPEN||Opendoor Technologies Inc.||18.39||-1.36||-6.89%||16.427M||10.936M||10.615B||N/A|
|TBVPF||Thai Beverage Public Company Limited||0.5550||-0.0400||-6.72%||24,507||38,077||14B||19.14|
|JMIA||Jumia Technologies AG||32.08||-2.15||-6.28%||7.711M||8.15M||3.163B||N/A|
|HBM||Hudbay Minerals Inc.||7.90||-0.52||-6.18%||1.588M||1.365M||2.059B||N/A|
|LSPD||Lightspeed POS Inc.||66.89||-4.12||-5.80%||2.018M||838,320||8.573B||N/A|
|NTLA||Intellia Therapeutics, Inc.||70.45||-4.32||-5.78%||907,785||1.558M||4.771B||N/A|
|AMC||AMC Entertainment Holdings, Inc.||9.33||-0.57||-5.76%||40.202M||172.791M||4.2B||N/A|
|TPTX||Turning Point Therapeutics, Inc.||73.03||-4.21||-5.45%||449,695||359,204||3.589B||N/A|
|RCUS||Arcus Biosciences, Inc.||33.13||-1.86||-5.32%||354,437||520,520||2.348B||N/A|
|FVRR||Fiverr International Ltd.||216.17||-12.04||-5.28%||670,256||1.12M||7.748B||N/A|
|UPST||Upstart Holdings, Inc.||104.65||-5.75||-5.21%||1.585M||2.39M||7.942B||N/A|
In this article we will take a look at the 10 best crypto, bitcoin stocks to buy instead of overvalued Coinbase. You can skip our comprehensive analysis of the crypto industry and go directly to the 5 Best Crypto, Bitcoin Stocks to Buy Instead of Overvalued Coinbase. San Francisco-based cryptocurrency exchange platform Coinbase Global, Inc. […]
Fourth-quarter revenue grew 76% year over year, and global monthly active users grew 37% year over year to 459 million. Adobe has strong fundamentals with positive earnings, positive cash flow from operations, and more short-term assets than debt. In its most recent quarter, Adobe achieved 26% year-over-year growth in revenue and increased its annual recurring revenue to $10.69 billion.
The cryptocurrency hasn’t always been as popular as it is now, in fact, it was first created as a joke by Jackson Palmer and Billy Markus in 2013.
Lightspeed POS Inc. (NYSE: LSPD) (TSX: LSPD), a leading provider of cloud-based, omnichannel commerce platforms, today announced the closing of the previously reported acquisition of Vend Limited (Vend), a cloud-based retail management software company headquartered in Auckland, New Zealand. Lightspeed finalized the acquisition for consideration of approximately $204.7 million in cash1 and the issuance of 2,692,277 subordinate voting shares in the capital of Lightspeed, subject to customary post-closing adjustments.
Pinterest stock fell sharply, apparently coming under pressure from a cautious research note on March-quarter financial results.
(Bloomberg) -- The sudden tumble in the shares of Pinterest Inc. Friday has one analyst defending the stock.Sanford C. Bernstein analyst Mark Shmulik brushed off speculation that channel checks for the social-media company have been relatively muted, saying the concerns were overblown. Pinterest shares fell as much as 11% Friday, the most in more than five months, which Shmulik said created a buying opportunity. The stock pared some losses to close down 9.7%.The analyst said channel checks for Pinterest are as strong as he has ever heard, acknowledging that they remain challenging, given that significant changes from large ad buyers can have a material impact. Shmulik has a market perform rating on the stock. It has 18 buys, 9 holds and one sell rating, according to data compiled by Bloomberg.Pinterest didn’t respond to a request for comment.San Francisco-based Pinterest is expected to report first-quarter results on April 27 after market close. The stock has gained 16% this year and hit a record as recently as Feb. 16.(Updates share moves and chart.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
HUMBL, Inc. HUMBL Pay Mobile Application San Diego, California, April 16, 2021 (GLOBE NEWSWIRE) -- HUMBL, Inc. (OTC Markets: HMBL) announced today that it is launching the first version of its HUMBL Pay™ mobile application, which will be made available after 2 PM PST. The HUMBL Pay mobile app will allow customers to discover merchants; as well as pay, tip, rate and review those same merchants in contactless transactions. The company has also integrated ticketing into the HUMBL Pay mobile application, for customers seeking to find and purchase tickets to live events; as well as click-through to HUMBL Financial™ services, along with third party credit and lending offers (US only). The HUMBL Pay mobile app will be rolled out in phases over the coming weeks. Phase I: United States, Canada, Mexico, Australia, Singapore and New Zealand Phase II: Austria, Belgium, Bulgaria, Switzerland, Cyprus, Czech Republic, Germany, Denmark, Estonia, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Norway, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia occurring in the coming weeks. Phase III: Brazil, India, Hong Kong, Japan, Malaysia HUMBL Pay is being built in a modular capacity, to support regional customization and future roadmap features, such as peer-to-peer transactions, digital asset investing and blockchain NFTs, which will include a broader list of countries than those listed above. The launch of the HUMBL Pay mobile application will be accompanied by outdoor media campaigns in the United States, Canada, Mexico, Australia and Singapore. About HUMBL HUMBL seamlessly connects consumers and merchants in the digital economy. HUMBL has three core business units: HUMBL Mobile, HUMBL Marketplace, and HUMBL Financial, which work together to package new technologies like mobile payments and digital assets for global consumers. CONTACT: HUMBL, Inc. investors@HUMBLpay.com Safe Harbor Disclaimer This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control. Attachment HUMBL, Inc.
A dramatically bearish analyst take has CRISPR stock Editas (NASDAQ:EDIT) down 15% in trading today, but it’s not the only one. Gene-editing stocks including Intellia Therapeutics (NASDAQ:NTLA) and CRISPR Therapeutics (NASDAQ:CRSP) are down 6% and 4% respectively. Source: vxhal/ShutterStock.com The downslide was triggered by Goldman Sachs initiating coverage of EDIT stock with a “sell” rating and a price target of just $20. Editas closed trading on Thursday at $40.98 and opened today at a price of $38.27. In his report, Goldman Sachs analyst Madhu Kumar expressed skepticism concerning the efficacy of EDIT’s experimental treatment for a rare eye disease. InvestorPlace analyst Luke Lango found Kumar’s report overly bearish, highlighting insider buying by the company’s CEO and a member of the board. Lango recommends investors buy EDIT stock on the dip.InvestorPlace - Stock Market News, Stock Advice & Trading Tips 10 Stocks at the Heart of Good Retirement Portfolios The decline in sector peers CRSP and NTLA appeared more sympathetic than tied to any particular news. CRISPR Therapeutics saw some gains earlier in the week which may help to explain why its stock deflated a little more than Intellia. Intellia has also seen increased investment from hedge funds in recent quarters, which could be a stabilizing force for NTLA stock. EDIT stock surged dramatically at the end of 2020 but has been steadily declining since a Jan. 8, 2021 peak above $90. The company has three other gene-editing treatments in progress, though none of those are as far along in development as its congenital amaurosis treatment. Editas reported full-year and Q4 earnings back in February. To learn more about investing in gene-editing stocks, check out our Guide to Investing in CRISPR Stocks. On the date of publication, Vivian Medithi did not have (either directly or indirectly) any positions in the securities mentioned in this article. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner Stock Prodigy Who Found NIO at $2… Says Buy THIS Now The post CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today appeared first on InvestorPlace.